Skip to main
ASTH

ASTH Stock Forecast & Price Target

ASTH Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 71%
Buy 29%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Astrana Health is a strong player in the healthcare industry, with a focus on population health management and coordinated, outcome-based care. Its three reportable segments, Care Partners, Care Delivery, and Care Enablement, generate the majority of its revenue and show the company's dedication to providing high-quality and cost-effective medical care. While there are risks in the industry, Astrana Health's strong fundamentals and efforts to address internal control issues make it a positive investment choice for the future.

Bears say

Astrana Health is a healthcare company that focuses on providing cost-effective, outcomes-based medical care to patients, particularly seniors and those with chronic conditions. While the company has shown good results in its REACH ACO programs and has strong technology solutions, its overall financials and business model may present challenges in the long term. In addition, while the company is currently trading at a lower EV/EBITDA multiple compared to its sub-sector average, it may not have the same level of growth potential as other players in the industry. As such, investors should be cautious and monitor the company's progress closely.

ASTH has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 71% of analysts recommend a Strong Buy, 29% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astrana Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astrana Health Inc (ASTH) Forecast

Analysts have given ASTH a Strong Buy based on their latest research and market trends.

According to 7 analysts, ASTH has a Strong Buy consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $47.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $47.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astrana Health Inc (ASTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.